Lantheus Holdings (LNTH) Current Assets (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Current Assets came in at $942.3 million in Q1 2026, down 33.82% year-on-year from $1.4 billion in Q1 2025, and up 4.7% on a QoQ basis from $900.0 million in Q4 2025.

Lantheus Holdings (LNTH) Current Assets (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Current Assets data on file, last reported at $942.3 million in Q1 2026.

  • On a quarterly basis, Current Assets fell 33.82% year-over-year to $942.3 million in Q1 2026; TTM through Mar 2026 was $942.3 million, a 33.82% decrease from a year earlier, with the FY2025 full-year figure at $900.0 million, down 32.16% from the prior year.
  • Current Assets for Q1 2026 stood at $942.3 million, up from $900.0 million in the prior quarter.
  • Over the last five years, Current Assets for LNTH reached as high as $1.4 billion in Q1 2025 and fell as low as $324.7 million in Q1 2022.
  • Historically, Current Assets has averaged $933.2 million across 5 years, with a median of $942.3 million in 2026.
  • Across the five-year window, Current Assets surged 187.38% in 2022 and tumbled 33.82% in 2026, its largest moves.
  • Year by year, Current Assets stood at $677.6 million in 2022, then surged by 60.24% to $1.1 billion in 2023, then grew by 22.18% to $1.3 billion in 2024, then tumbled by 32.16% to $900.0 million in 2025, then climbed by 4.7% to $942.3 million in 2026.
  • Per Business Quant data, the three most recent Current Assets figures were $942.3 million in Q1 2026, $900.0 million in Q4 2025, and $925.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.05 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.71 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 6.47 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 19.71 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 2.87 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 53.60 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 10.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.44 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.58 Bn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn 942.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 942.29 Mn
Dec 31, 2025 899.96 Mn
Sep 30, 2025 925.09 Mn
Jun 30, 2025 1.20 Bn
Mar 31, 2025 1.42 Bn
Dec 31, 2024 1.33 Bn
Sep 30, 2024 1.30 Bn
Jun 30, 2024 1.23 Bn
Mar 31, 2024 1.15 Bn
Dec 31, 2023 1.09 Bn
Sep 30, 2023 948.44 Mn
Jun 30, 2023 752.22 Mn
Mar 31, 2023 773.27 Mn
Dec 31, 2022 677.62 Mn
Sep 30, 2022 501.90 Mn
Jun 30, 2022 404.42 Mn
Mar 31, 2022 324.75 Mn
Dec 31, 2021 235.79 Mn
Sep 30, 2021 201.52 Mn
Jun 30, 2021 186.21 Mn